| Trial ID: | L5308 |
| Source ID: | NCT03991299
|
| Associated Drug: |
Botox 200 Unt Injection
|
| Title: |
Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT03991299/results
|
| Conditions: |
Obese|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Botox 200 UNT Injection
|
| Outcome Measures: |
Primary: Change in Body Weight at 6 Months, Body weight will be measured at baseline and 6 months after Botox injections., Baseline - 6 months|Change in Body Weight at 3 Months, Body weight will be measured at baseline and 3 months after Botox injections., Baseline - 3 months|Change in Body Weight at 1 Month, Body weight will be measured at baseline and 1 month after Botox injections., Baseline - 1 month |
|
| Sponsor/Collaborators: |
Sponsor: Vanderbilt University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
4
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2021-04-29
|
| Completion Date: |
2022-02-11
|
| Results First Posted: |
2023-02-28
|
| Last Update Posted: |
2023-02-28
|
| Locations: |
Vanderbilt University Medical Center, Nashville, Tennessee, 37232-6602, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03991299
|
